• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Immune Pharmaceuticals Inc

+ Add to Watchlist

IMNP:SS

23.4000 SEK 1.4000 5.65%

As of 12:00:00 ET on 07/22/2014.

Snapshot for Immune Pharmaceuticals Inc (IMNP)

Open: 24.1000 Day's Range: 22.0000 - 24.8000 Volume: 18,431
Previous Close: 24.8000 52wk Range: 10.4000 - 36.0000 1-Yr Rtn: +46.25%

Stock Chart for IMNP

No chart data available.
  • IMNP:SS 22.7000
  • 1D
  • 1M
  • 1Y
24.8000
Interactive IMNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMNP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -0.4070
Est. PEG Ratio -
Market Cap (M SEK) 337.79
Shares Outstanding (M) 14.44
30 Day Average Volume 9,628
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMNP

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for IMNP

Immune Pharmaceuticals Inc. is a biopharmaceutical company. The Company focuses on the development of antibody therapeutics to address medical needs in the treatment of inflammatory diseases and cancer.

Daniel Geodeon TeperChairman/CEORobert W CookSenior VP:F&A/Secretary
Anna BaranDir:Investor Relations
More Company Profile & Key Executives for IMNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil